Estia Health Ltd (ASX:EHE) shares fall on disappointing full-year results

The Estia Health Ltd (ASX:EHE) share price has tumbled lower following the release of a disappointing full-year result…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The Estia Health Ltd (ASX: EHE) share price has tumbled lower on Thursday following the release of its full-year results.

In early afternoon trade the aged care operator's shares are down almost 1% to $3.14.

Here is a summary of FY 2018 compared to the prior corresponding period:

  • Operating revenue increased 4.3% to $547.1 million.
  • EBITDA up 4.1% to $90.1 million.
  • Net profit after tax rose 1.1% to $41.2 million, equating to earnings per share of 15.7 cents.
  • Average occupancy improved to 94.2% from 93.5%.
  • Net RAD receipts of $62.8 million.
  • Net bank debt reduced to $63.8 million.
  • Fully franked final dividend of 8 cents per share declared.
  • Outlook: Mid-single digit percentage increase in EBITDA on its existing portfolio of homes in FY 2019.

I thought this was a disappointing performance from Estia Health and I can't say I'm overly surprised to see its shares drift lower despite already being down significantly year-to-date.

Although EBITDA grew 4.1% over the 12 months, it has slowed down from the first-half when it grew 5.6% on the prior corresponding period. I estimate that second-half EBITDA grew just 2.5% despite improvements in its occupancy levels.

Management has blamed staff cost pressures on its EBITDA margin weakness. Thankfully this was offset slightly by achieving further improvements in non-wage costs.

CEO Norah Barlow believes things could improve in the future. Stating that: "We are confident about the future of the company and the fundamentals of the industry in which we operate. The past 12 to 18 months has seen us shift from stabilising the business to optimising its financial and operating performance and ensuring Estia is in a position to capture the tremendous growth opportunities that exist, now and in the future."

Should you invest?

While I do believe that Australia's ageing population should put Estia and rivals Japara Healthcare Ltd (ASX: JHC) and Regis Healthcare Ltd (ASX: REG) in a position to profit greatly in the future, it may be a few years before these benefits are reflected in their earnings growth.

Because of this, I see more value in the shares of growing home care provider Zenitas Healthcare Ltd (ASX: ZNT).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Zenitas Healthcare Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Cochlear, Karoon Energy, Origin Energy, and WiseTech shares are falling today

These shares are starting the week in the red. Let's find out why.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Brainchip, Fortescue, IGO, and Life360 shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

a woman sits next to her computer screen with her head in her hands with the screens slowing graphs on downward trajectories.
52-Week Lows

Can the beaten-down CSL share price ever reach $300 again?

CSL is near decade lows. Can it ever climb back?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Black Cat, Mirvac, Qantas, and Temple & Webster shares are falling today

These shares are having a tough session. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Bank of Queensland, Cochlear, Northern Star, and Paladin Energy shares are falling today

These shares are having a difficult time on hump day. But why?

Read more »

An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
Share Fallers

Why ANZ, Challenger, Hub24, and Lynas shares are dropping today

These shares are under pressure on Tuesday. But why?

Read more »